These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 7511976

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Behavioural effects of tachykinins and related peptides.
    Elliott PJ, Iversen SD.
    Brain Res; 1986 Aug 27; 381(1):68-76. PubMed ID: 2428433
    [Abstract] [Full Text] [Related]

  • 29. Bronchoconstrictor effect of the tachykinin NK₃-receptor agonists [MePhe⁷]-neurokinin B and senktide in the isolated guinea pig lung.
    Corboz MR, Rivelli MA, Eckel SP.
    Exp Lung Res; 2010 Nov 27; 36(9):509-21. PubMed ID: 20939761
    [Abstract] [Full Text] [Related]

  • 30. The NK-3 tachykinin receptor agonist senktide elicits 5-HT-mediated behaviour following central or peripheral administration in mice and rats.
    Stoessl AJ, Dourish CT, Iversen SD.
    Br J Pharmacol; 1988 Jun 27; 94(2):285-7. PubMed ID: 2456111
    [Abstract] [Full Text] [Related]

  • 31. Are biological actions of neurokinin A in the adult brain mediated by a cross-talk between the NK1 and NK2 receptors?
    Tauer U, Zhao Y, Hunt SP, Culman J.
    Neuropharmacology; 2012 Nov 27; 63(6):958-65. PubMed ID: 22771977
    [Abstract] [Full Text] [Related]

  • 32. A novel role for tachykinin neurokinin-3 receptors in regulation of human bronchial Ganglia neurons.
    Myers AC, Goldie RG, Hay DW.
    Am J Respir Crit Care Med; 2005 Feb 01; 171(3):212-6. PubMed ID: 15477495
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. The behavioural effects of a novel substance P analogue following infusion into the ventral tegmental area or substantia nigra of rat brain.
    Eison AS, Eison MS, Iversen SD.
    Brain Res; 1982 Apr 22; 238(1):137-52. PubMed ID: 6177380
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Demonstration of a 'septide-sensitive' inflammatory response in rat skin.
    Ahluwalia A, Giuliani S, Maggi CA.
    Br J Pharmacol; 1995 Oct 22; 116(4):2170-4. PubMed ID: 8564245
    [Abstract] [Full Text] [Related]

  • 39. Intranigral antagonism of neurokinin 1 and 3 receptors reduces intrastriatal dopamine D1 receptor-stimulated locomotion in the rat.
    Bishop C, Walker PD.
    Brain Res; 2004 Oct 08; 1023(1):126-33. PubMed ID: 15364027
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.